Neocutis

Neocutis S.A., founded in February 2003, is a specialty bio-pharmaceutical company that spun off from the Medical School of the University Hospital of Lausanne, Switzerland, where medical researchers created a biotechnology process to extract the rich proteins responsible for scarless wound healing from cultured fetal skin cells. Originally established for wound healing and burn treatments, today the cell bank they established also provides a lasting supply of cells for producing the NEOCUTIS proprietary skin care ingredient Processed Skin Cell Proteins (PSP®).

PSP® provides a complete and balanced combination of growth factors and cytokines, helping to restore a smoother, softer and more vibrant tone and texture to the skin. Whether your skin has been damaged by trauma or time, NeoCutis helps to restore a healthier appearance with continued use, reducing the signs of aging, scarring and other forms of damage.